Poland - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Poland Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale jumped by 5.1% year on year. In 2019, the country was number 10 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale with €51,366,842.93. Poland is overtaken by Netherlands, which was ranked number 9 with €62,791,131.78 and is followed by Greece with €11,899,027.15. Denmark ranked the highest with €3,801,340,964.3 in 2019, that is a fall of 2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 51,366,842.93
2018 55,223,794.00
2017 45,532,817.00
2016 59,680,143.00
2015 51,912,454.00
Download all data from 2002 to 2019

How does Poland rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
9 #9
Netherlands
62,791,131.78 2019 -8.2 % -13.4 % View data
10 #10
Poland
51,366,842.93 2019 -7.0 % +5.1 % View data
11 #11
Greece
11,899,027.15 2019 +17.2 % -1.1 % View data
Compare all 16 countries

Go Top